Gil H, Bouldoires B, Bailly B, Meaux Ruault N, Humbert S, Magy-Bertrand N
Service de médecine interne, CHU Jean-Minjoz, 25000 Besançon, France.
Service de médecine interne, CHU Jean-Minjoz, 25000 Besançon, France.
Rev Med Interne. 2019 Mar;40(3):173-177. doi: 10.1016/j.revmed.2018.11.008. Epub 2018 Nov 27.
Since 1893, eosinopenia is a biological test to help a diagnosis of bacterial infection. Several publications have confirmed this hypothesis, particularly in the intensive care, pneumology and pediatric units. The value of this marker has been identified in vascular cerebral diseases and coronary bypass. Its contribution seems as relevant as procalcitonin, without extra cost. The diagnostic performance of this test was reinforced by a composite score (CIBLE score) that may improve its value in daily routine. Finally, monitoring eosinopenia appears to be a reliable mortality marker.
自1893年以来，嗜酸性粒细胞减少是一种有助于诊断细菌感染的生物学检测方法。一些出版物证实了这一假设，特别是在重症监护、肺病学和儿科病房。这一标志物在脑血管疾病和冠状动脉搭桥手术中的价值已得到确认。其作用似乎与降钙素原相当，且无需额外费用。该检测的诊断性能通过一个综合评分（CIBLE评分）得到加强，这可能会提高其在日常临床中的价值。最后，监测嗜酸性粒细胞减少似乎是一个可靠的死亡标志物。
